BMS-986016
BMS-986016 Uses, Dosage, Side Effects, Food Interaction and all others data.
BMS-986016 is under investigation in clinical trial NCT02966548 (Safety Study of BMS-986016 With or Without Nivolumab in Patients With Advanced Solid Tumors).
Trade Name | BMS-986016 |
Generic | Relatlimab |
Relatlimab Other Names | BMS-986016, Relatlimab |
Type | |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here BMS-986016